Exact Sciences to Participate in September Investor Conferences

MADISON, Wis.--(BUSINESS WIRE)-- Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conferences and invited investors to participate by webcast.

• Wells Fargo Healthcare Conference, Boston
  Fireside chat on Wednesday, September 4, 2024 at 3:45 p.m. ET
  

• Baird Global Healthcare Conference, New York
  Fireside chat on Wednesday, September 11, 2024 at 10:15 a.m. ET

The webcasts can be accessed in the investor relations section of Exact Sciences' website at www.exactsciences.com .

About Exact Sciences Corp.

A leading provider of cancer screening and diagnostic tests, Exact Sciences gives patients and health care professionals the clarity needed to take life-changing action earlier. Building on the success of the Cologuard ^® and Oncotype ^® tests, Exact Sciences is investing in its pipeline to develop innovative solutions for use before, during, and after a cancer diagnosis. For more information, visit ExactSciences.com , follow Exact Sciences on X (formerly known as Twitter) @ExactSciences , or find Exact Sciences on LinkedIn and Facebook .